These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9721874)

  • 1. Complete regression of established human glioblastoma tumor xenograft by interleukin-4 toxin therapy.
    Husain SR; Behari N; Kreitman RJ; Pastan I; Puri RK
    Cancer Res; 1998 Aug; 58(16):3649-53. PubMed ID: 9721874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-13 receptor as a unique target for anti-glioblastoma therapy.
    Husain SR; Joshi BH; Puri RK
    Int J Cancer; 2001 Apr; 92(2):168-75. PubMed ID: 11291041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human breast carcinoma cells express type II IL-4 receptors and are sensitive to antitumor activity of a chimeric IL-4-Pseudomonas exotoxin fusion protein in vitro and in vivo.
    Leland P; Taguchi J; Husain SR; Kreitman RJ; Pastan I; Puri RK
    Mol Med; 2000 Mar; 6(3):165-78. PubMed ID: 10965493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical development of a recombinant toxin containing circularly permuted interleukin 4 and truncated Pseudomonas exotoxin for therapy of malignant astrocytoma.
    Puri RK; Hoon DS; Leland P; Snoy P; Rand RW; Pastan I; Kreitman RJ
    Cancer Res; 1996 Dec; 56(24):5631-7. PubMed ID: 8971168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-4 receptor cytotoxin as therapy for human malignant pleural mesothelioma xenografts.
    Beseth BD; Cameron RB; Leland P; You L; Varricchio F; Kreitman RJ; Maki RA; Jablons DM; Husain SR; Puri RK
    Ann Thorac Surg; 2004 Aug; 78(2):436-43; discussion 436-43. PubMed ID: 15276492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased antitumor activity of a circularly permuted interleukin 4-toxin in mice with interleukin 4 receptor-bearing human carcinoma.
    Kreitman RJ; Puri RK; Pastan I
    Cancer Res; 1995 Aug; 55(15):3357-63. PubMed ID: 7614471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-13 fusion cytotoxin as a potent targeted agent for AIDS-Kaposi's sarcoma xenograft.
    Husain SR; Puri RK
    Blood; 2000 Jun; 95(11):3506-13. PubMed ID: 10828036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a recombinant interleukin-4-Pseudomonas exotoxin for therapy of glioblastoma.
    Puri RK
    Toxicol Pathol; 1999; 27(1):53-7. PubMed ID: 10367674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-4 receptor-directed cytotoxin therapy of AIDS-associated Kaposi's sarcoma tumors in xenograft model.
    Husain SR; Kreitman RJ; Pastan I; Puri RK
    Nat Med; 1999 Jul; 5(7):817-22. PubMed ID: 10395328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An improved circularly permuted interleukin 4-toxin is highly cytotoxic to human renal cell carcinoma cells. Introduction of gamma c chain in RCC cells does not improve sensitivity.
    Puri RK; Leland P; Obiri NI; Husain SR; Mule J; Pastan I; Kreitman RJ
    Cell Immunol; 1996 Jul; 171(1):80-6. PubMed ID: 8660841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 4 receptor-directed cytotoxin therapy for human head and neck squamous cell carcinoma in animal models.
    Strome SE; Kawakami K; Alejandro D; Voss S; Kasperbauer JL; Salomao D; Chen L; Maki RA; Puri RK
    Clin Cancer Res; 2002 Jan; 8(1):281-6. PubMed ID: 11801570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxins directed at interleukin-4 receptors as therapy for human brain tumors.
    Puri RK
    Methods Mol Biol; 2001; 166():155-76. PubMed ID: 11217365
    [No Abstract]   [Full Text] [Related]  

  • 13. Intratumoral administration of recombinant circularly permuted interleukin-4-Pseudomonas exotoxin in patients with high-grade glioma.
    Rand RW; Kreitman RJ; Patronas N; Varricchio F; Pastan I; Puri RK
    Clin Cancer Res; 2000 Jun; 6(6):2157-65. PubMed ID: 10873064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-4 receptors on human medulloblastoma tumours serve as a sensitive target for a circular permuted IL-4-Pseudomonas exotoxin fusion protein.
    Joshi BH; Leland P; Silber J; Kreitman RJ; Pastan I; Berger M; Puri RK
    Br J Cancer; 2002 Jan; 86(2):285-91. PubMed ID: 11870521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-4 receptors expressed on tumor cells may serve as a target for anticancer therapy using chimeric Pseudomonas exotoxin.
    Debinski W; Puri RK; Pastan I
    Int J Cancer; 1994 Sep; 58(5):744-8. PubMed ID: 8077061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human neurological cancer cells express interleukin-4 (IL-4) receptors which are targets for the toxic effects of IL4-Pseudomonas exotoxin chimeric protein.
    Puri RK; Leland P; Kreitman RJ; Pastan I
    Int J Cancer; 1994 Aug; 58(4):574-81. PubMed ID: 8056454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 4 receptor on human lung cancer: a molecular target for cytotoxin therapy.
    Kawakami M; Kawakami K; Stepensky VA; Maki RA; Robin H; Muller W; Husain SR; Puri RK
    Clin Cancer Res; 2002 Nov; 8(11):3503-11. PubMed ID: 12429641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant immunotoxins containing anti-Tac(Fv) and derivatives of Pseudomonas exotoxin produce complete regression in mice of an interleukin-2 receptor-expressing human carcinoma.
    Kreitman RJ; Bailon P; Chaudhary VK; FitzGerald DJ; Pastan I
    Blood; 1994 Jan; 83(2):426-34. PubMed ID: 8286741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human renal cell carcinoma cells are sensitive to the cytotoxic effect of a chimeric protein composed of human interleukin-4 and Pseudomonas exotoxin.
    Puri RK; Debinski W; Obiri N; Kreitman R; Pastan I
    Cell Immunol; 1994 Apr; 154(1):369-79. PubMed ID: 8131209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-4 receptor expression on AIDS-associated Kaposi's sarcoma cells and their targeting by a chimeric protein comprised of circularly permuted interleukin-4 and Pseudomonas exotoxin.
    Husain SR; Gill P; Kreitman RJ; Pastan I; Puri RK
    Mol Med; 1997 May; 3(5):327-38. PubMed ID: 9205948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.